MetLife Investment Management, LLC
Position in DYN — Dyne Therapeutics, Inc.
CIK 1529735
Whippany, NJ
Position in DYN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,320,607
-$40,749 QoQ
Shares Held
72,841
+4.7% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $374,503,407 across 207 Biotechnology names. DYN ranks #54 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
70,804 | $31,616,818 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
80,930 | $26,074,836 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
152,645 | $25,800,057 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
374,931 | $24,231,790 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23,567 | $18,208,806 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
1,805,184 | $17,004,833 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,738,062 | $15,659,938 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.DE
|
708,527 | $13,858,788 |
All Filings in DYN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,320,607 | 72,841 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,361,356 | 69,599 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $812,395 | 64,221 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $541,154 | 56,844 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $510,406 | 48,796 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,165,442 | 49,467 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,678,146 | 46,719 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,648,713 | 46,719 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $865,383 | 30,482 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $305,008 | 22,933 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $205,479 | 22,933 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $257,996 | 22,933 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $227,704 | 19,766 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $229,087 | 19,766 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $251,028 | 19,766 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $135,792 | 19,766 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $190,544 | 19,766 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $149,647 | 12,586 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $204,396 | 12,586 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $264,809 | 12,586 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $157,059 | 7,479 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||